7
070
Iijima, T.; Endo, Y.; Tsuji, M.; Kawachi, E.; Kagechika, H.; Shudo, K. Chem. Pharm. Bull. 1999, 47, 398±404.
Endo, Y.; Iijima, T.; Yamakoshi, Y.; Yamaguchi, M.; Fukasawa, H.; Shudo, K. J. Med. Chem. 1999, 42, 1501±
1
504. Endo, Y.; Iijima, T.; Yamakoshi, Y., Kubo, A.; Itai, A. Biomed. Chem. Lett. 1999, 9, 3313±3318. Endo, Y.;
Yoshimi, T.; Iijima, T.; Yamakoshi, Y. Biomed. Chem. Lett. 1999, 9, 3387±3392. Endo, Y.; Yoshimi, T.;
Yamakoshi, Y. Chem. Pharm. Bull. 2000, 48, 312±314.
. Housecroft, C. E. Angew. Chem., Int. Ed. Engl. 1999, 38, 2717±2719.
. Hardie, M. T.; Raston, C. L. Chem. Commun. 1999, 1153±1163: Hardie, M. T.; Godfrey, P. D.; Raston, C. L.
Chem. Eur. J. 1999, 5, 1828±1833.
6
7
8
. Clegg, E.; Gill, W. R.; MacBride, J. A. H.; Wade, K. Angew. Chem., Int. Ed. Engl. 1993, 32, 1328. Zheng, Z. P.;
Diaz, M.; Knobler, C. B.; Hawthorne, M. F. J. Am. Chem. Soc. 1995, 117, 12338±12339.
. Itai, A.; Toriumi, Y.; Saito, S.; Kagechika, H.; Shudo, K. J. Am. Chem. Soc. 1992, 114, 10649±10650. Azumaya,
I.; Yamaguchi, K.; Okamoto, I.; Kagechika, H.; Shudo, K. J. Am. Chem. Soc. 1995, 117, 9083±9084.
9
1
0. Tanatani, A.; Kagechika, H.; Azumaya, I.; Fukutomi, R; Ito, Y.; Yamaguchi, K; Shudo, K. Tetrahedron Lett.
997, 38, 4425±4428.
1. Yamaguchi, K.; Matsumura, G.; Kagechika, H.; Azumaya, I.; Ito, Y.; Itai, A.; Shudo, K. J. Am. Chem. Soc. 1991,
13, 5474±5475.
1
1
1
1
1
1
1
2. Saito, S.; Toriumi, Y.; Tomioka, N.; Itai, A. J. Org. Chem. 1995, 60, 4715±4720.
3. Hawthorne, M. F.; Berry, T. E.; Wegner, P. A. J. Am. Chem. Soc. 1965, 87, 4746±4750.
4. Ozasa, S.; Fujioka, Y.; Kikutake, J.; Ibuki, E. Chem. Pharm. Bull. 1983, 31, 1572±1581.
ꢀ
1
5. Compound 1a: mp 270±271 C (n-hexane±ethyl acetate). H NMR (400 MHz, DMSO-d
.73 (s, 2H), 7.19 (dd, J=7.7, 1.8 Hz, 2H), 7.31 (t, J=7.9, Hz, 2H), 7.51 (dd, J=7.7, 1.8 Hz, 2H), 7.75 (t, J=1.8
Hz, 2H), 8.96 (s, 2H). Anal. calcd for C H B N O: C, 41.11; H, 6.49; N, 5.64. Found: C, 40.94; H, 6.36; N, 5.43.
6
) ꢀ 1.3±3.2 (br m, 20H),
5
1
7
32 20
2
ꢀ
1
3
Compound 1b: mp >298 C (n-hexane±dichloromethane). H NMR (400 MHz, CDCl ) ꢀ 1.4±3.1 (br m, 20H),
3
.88 (br, s, 1H), 6.48 (s, 1H), 7.33 (d, J=8.8 Hz, 2H), 7.43 (d, J=8.9 Hz, 2H). Anal. calcd for C17
H
32
B
20
N
2
O: C,
1.11; H, 6.49; N, 5.64. Found: C, 40.88; H, 6.32; N, 5.52. Compound 2a: mp 287±288 C (n-hexane±
ꢀ
4
dichloromethane). H NMR (400 MHz, DMSO-d
1
6
) ꢀ 1.4±3.0 (br m, 20H), 3.11 (s, 6H), 5.67 (br s, 2H), 6.92 (m,
2
6
H), 6.96 (s, 2H), 7.10 (m, 4H). Anal. calcd for C19 O: C, 43.49; H, 6.92; N, 5.34. Found: C, 43.25; H,
ꢀ
36 20 2
H B N
1
.74; N, 5.04. Compound 2b: mp 268±269 C (n-hexane±dichloromethane). H NMR (400 MHz, CDCl ) ꢀ 1.6±3.2
3
(
br m, 20H), 3.36 (s, 6H), 3.81 (br s, 2H), 6.74 (d, J=8.8 Hz, 4H), 7.16 (d, J=8.8 Hz, 4H). Anal. calcd for
ꢀ
C B
hexane±dichloromethane). H NMR (400 MHz, CDCl
19
H
36
20
N
2
O: C, 43.49; H, 6.92; N, 5.34. Found: C, 43.22; H, 6.80; N, 5.41. Compound 1c: mp 294±295 C (n-
1
3
) ꢀ 1.5±3.4 (br m, 40H), 3.96 (br s, 4H), 6.97 (br s, 2H),
7
.31 (t, J=1.7 Hz, 2H), 7.60 (d, J=1.7 Hz, 4H). Anal. calcd for C H B N O: C, 32.29; H, 6.71; N, 3.59. Found:
2
21
52 40
ꢀ
1
C, 32.27; H, 6.61; N, 3.59. Compound 2c: mp >298 C (n-hexane±dichloromethane). H NMR (400 MHz, CDCl
1.6±3.2 (br m, 40H), 3.17 (s, 6H), 3.81 (br s, 4H), 6.99 (d, J=1.7 Hz, 4H), 7.22 (d, J=1.7 Hz, 2H). Anal. calcd
for C H B N O: C, 34.14; H, 6.98; N, 3.46. Found: C, 34.15; H, 6.93; N, 3.59.
3
)
ꢀ
2
3
56 40
2
Ê
1
6. Crystal data of the ureas. Compound 1a: orthorhombic; space group, Pcca; Z=4; a=22.393(2) A; b=13.9983(8)
3
Ê
Ê
Ê
3
1
A; c=10.0129(8) A; V=3138.7(3) A ; Dcalc=1.051 g/cm ; R=0.100. Compound 1b: monoclinic; space group, P2 /
Ê
Ê
Ê
ꢀ
Ê
3
3
c; Z=8; a=15.194(7) A; b=22.088(7) A; c=17.80(1) A; b=101.48(4) ; V=5927(4) A ; D =1.113 g/cm ;
calc
Ê
R=0.096. Compound 2a: triclinic; space group, P-1; Z=2; a=11.10(1) A; b=13.34(2) A; c=10.98(2) A;
Ê
Ê
ꢀ ꢀ ꢀ
Ê
3
3
ꢁ
=112.15(6) ; ꢂ=96.18(9) ; ꢃ=85.16(7) ; V=1495(3) A ; Dcalc=1.165 g/cm ; R=0.092. Compound 2b:
triclinic; space group, P-1; Z=2; a=11.0843(4) A; b=12.8759(5) A; c=13.1756(4) A; ꢁ=83.069(2) ;
Ê
Ê
Ê
ꢀ
ꢀ
ꢀ
Ê
3
3
ꢂ=85.0080(10) ; ꢃ=64.9700(10) ; V=1690.03(10) A ; D =1.129 g/cm ; R=0.085. Compound 2c: monoclinic;
calc
Ê Ê Ê Ê
ꢀ
space group, P2
3;
calc=1.160 g/cm ; R=0.090. There are unre®ned solvent molecules in the unit cells of 2b and 2c. The
1
/c; Z=4; a=12.139(1) A; b=22.920(2) A; c=22.474(2) A; ꢂ=100.756(2) ; V=6143.4(8) A
3
D
preliminary crystallographical analysis indicated (trans, trans) conformation of 1c, but the presence of several
unre®ned solvents, which made it impossible to re®ne the data. No signi®cant changes in the bond lengths and
0
bond angles of the urea bonds were observed by introduction of carborane moieties on N,N -diphenylurea or
0
0
N,N -dimethyl-N,N -diphenylurea skeletons.
7. Dannecker, W.; Kopf, J.; Rust, E. Cryst. Struct. Commun. 1979, 8, 429±432.
8. Jorgensen, W. L.; Severance, D. L. J. Am. Chem. Soc. 1990, 112, 4768±4774. Hobza, P.; Selzle, H. L.; Schlag, E. W.
J. Am. Chem. Soc. 1994, 116, 3500±3506. Azumaya, I.; Kagechika, H.; Yamaguchi, K.; Shudo, K. Tetrahedron
1
1
1995, 51, 5277±5290.
9. Fukutomi, R.; Tanatani, A.; Kakuta, H.; Tomioka, N.; Itai, A.; Hashimoto, Y.; Shudo, K.; Kagechika, H.
Tetrahedron Lett. 1998, 39, 6475±6478.
1